Inaugural PCR for Molecular Medicine

Polymerase chain reaction (PCR) is a staple in diagnostic labs worldwide with applications ranging from cancer to infectious diseases. Today, advances in PCR have sparked innovation, expanded research capabilities, and made the technology more clinically useful than ever. Cambridge Healthtech Institute's Inaugural PCR for Molecular Medicine will showcase novel technology platforms such as digital PCR, as well as high-throughput platforms and improvements in automation and standardization. Case studies in cancer, infectious diseases, and prenatal diagnosis will be presented to illustrate how PCR is being used in patient diagnosis and monitoring. PCR for Molecular Medicine will provide a comprehensive look at PCR in both the research and clinical setting as well as insight into advanced techniques and tools for effective disease diagnosis.